首页> 外文期刊>American Journal of Pathology >Development of Arterial Blood Supply in Experimental Liver Metastases
【24h】

Development of Arterial Blood Supply in Experimental Liver Metastases

机译:实验性肝转移中动脉血供的发展

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we present a mechanism for the development of arterial blood supply in experimental liver metastases. To analyze the arterialization process of experimental liver metastases, we elucidated a few key questions regarding the blood supply of hepatic lobules in mice. The microvasculature of the mouse liver is characterized by numerous arterioportal anastomoses and arterial terminations at the base of the lobules. These terminations supply one hepatic microcirculatory subunit per lobule, which we call an arterial hepatic microcirculatory subunit (aHMS). The process of arterialization can be divided into the following steps: 1) distortion of the aHMS by metastasis; 2) initial fusion of the sinusoids of the aHMS at the tumor parenchyma interface; 3) fusion of the sinusoids located at the base of the aHMSs, which leads to the disruption of the vascular sphincter (burst pipe); 4) incorporation of the dilated artery and the fused sinusoids into the tumor; and 5) further development of the tumor vasculature (arterial tree) by proliferation, remodeling, and continuous incorporation of fused sinusoids at the tumor–parenchyma interface. This process leads to the inevitable arterialization of liver metastases above the 2000- to 2500-µm size, regardless of the origin and growth pattern of the tumor.
机译:在这项研究中,我们提出了在实验性肝转移中 动脉血供发展的机制。为了分析实验性肝转移的 动脉化过程,我们阐明了有关小鼠肝小叶供血 的几个关键问题。小鼠 肝的微脉管系统的特征是许多动静脉吻合和小叶基部的动脉末端。这些 端接每个 小叶提供一个肝微循环亚基,我们称其为动脉肝微循环亚基 (aHMS)。动脉化过程可分为以下步骤:1)转移引起的aHMS畸变; 2) aHMS正弦曲线在肿瘤实质 界面的初始融合; 3)位于 aHMS底部的正弦曲线融合,导致血管括约肌 (爆裂管)破裂; 4)将扩张的动脉和 融合的正弦波合并到肿瘤中;和5)通过扩散,重塑, 以及在肿瘤-实质中不断掺入融合的正弦曲线来进一步发展 肿瘤脉管系统(动脉树)接口。无论肿瘤的起源和生长方式如何,此过程都会导致2000-2500微米以上的肝脏转移发生不可避免的动脉化。 上>

著录项

  • 来源
    《American Journal of Pathology》 |2009年第2期|835-843|共9页
  • 作者单位

    From the First Institute of Pathology and Experimental Cancer Research,Semmelweis University, Budapest, Hungary;

    From the First Institute of Pathology and Experimental Cancer Research,Semmelweis University, Budapest, Hungary;

    From the First Institute of Pathology and Experimental Cancer Research,Semmelweis University, Budapest, Hungary;

    From the First Institute of Pathology and Experimental Cancer Research,Semmelweis University, Budapest, Hungary;

    the Department of Tumor Biology,National Koranyi Institute of Pulmonology, Budapest, Hungary|and the Department of Cardio-Thoracic Surgery,Medical University of Vienna, Vienna, Austria;

    the Department of Tumor Biology,National Koranyi Institute of Pulmonology, Budapest, Hungary;

    and the 2nd Department of Pathology,Semmelweis University, Budapest, Hungary;

    From the First Institute of Pathology and Experimental Cancer Research,Semmelweis University, Budapest, Hungary;

    From the First Institute of Pathology and Experimental Cancer Research,Semmelweis University, Budapest, Hungary;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号